Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Brilaroxazine in acute schizophrenia or schizoaffective disorder
NCT01490086Phase 2Completed
- Sponsor
- Reviva Pharmaceuticals
- Start
- Dec 2011
- Primary completion
- Mar 2013
- Modality
- Small Molecules
- Countries
- 5
01
Overview
A Phase 2 trial of brilaroxazine in schizophrenia, schizoaffective disorder, sponsored by Reviva Pharmaceuticals. Started Dec 2011; status: completed.
02
Drugs
brilaroxazine
03
Conditions
schizophreniaschizoaffective disorder
Beyond the preview
Go deeper on NCT01490086.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01490086.